Responses
Regular and young investigator award abstracts
Clinical trials in progress
408 Phase I, first-in-human trial evaluating BI 1387446 (stimulator of interferon genes [STING] agonist) alone and combined with BI 754091 (anti-programmed cell death [PD]-1) in solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.
